Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
2.
J Postgrad Med ; 68(1): 38-40, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34121670

RESUMEN

Pembrolizumab (an immune checkpoint inhibitor)-related gastritis and gastric ulcers are rare immune-related adverse events, which are insufficiently treated with proton pump inhibitors (PPIs) therapy alone, and usually require systemic steroid therapy and even other biological agents (such as infliximab) in severe cases. Here, we report a case of 49-years-old woman suffering from gastritis and gastric ulcers after pembrolizumab treatment, which was refractory to 2 months of PPI therapy. The diagnosis was made by the clinical and histopathologic presentations. She had immediate resolution of abdominal symptoms after initiation of steroid treatment, but the gastritis and gastric ulcers improved slowly and lasted for months as shown in endoscopy. She was finally treated with extended steroid therapy without serious complications. We discuss the latest treatment options and our management strategies of the case.


Asunto(s)
Gastritis , Úlcera Gástrica , Anticuerpos Monoclonales Humanizados/efectos adversos , Endoscopía Gastrointestinal , Femenino , Gastritis/inducido químicamente , Gastritis/tratamiento farmacológico , Humanos , Persona de Mediana Edad , Inhibidores de la Bomba de Protones/efectos adversos , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/tratamiento farmacológico
3.
Lupus ; 28(8): 945-953, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31177913

RESUMEN

The Fracture Risk Assessment Tool (FRAX) has been used universally for the purpose of fracture risk assessment. However, the predictive capacity of FRAX for autoimmune diseases remains inconclusive. This study aimed to compare the applicability of FRAX for autoimmune disease patients. This retrospective study recruited rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and primary Sjögren syndrome (pSS) patients with bone mineral density (BMD) tests. Patients with any osteoporotic fractures were identified. Taiwan-specific FRAX with and without BMD were then calculated. In total, 802 patients (451 RA, 233 SLE and 118 pSS) were enrolled in this study. The cumulative incidences of osteoporotic fractures in the RA, SLE and pSS patients were 43.0%, 29.2% and 33.1%, respectively. For those with a previous osteoporotic fracture, T-scores were classified as low bone mass. Overall, the patients' 10-year probability of major fracture risk by FRAX without BMD was 15.8%, which then increased to 20.3% after incorporation of BMD measurement. When analyzed by disease group, the fracture risk in RA patients was accurately predicted by FRAX. In contrast, current FRAX, either with or without BMD measurement, underestimated the fracture risk both in SLE and pSS patients, even after stratification by age and glucocorticoid treatment. For pSS patients with major osteoporotic fractures, FRAX risks imputed by RA were comparable to major osteoporotic fracture risks of RA patients. Current FRAX accurately predicted fracture probability in RA patients, but not in SLE and pSS patients. RA-imputed FRAX risk scores could be used as a temporary substitute for SLE and pSS patients.


Asunto(s)
Artritis Reumatoide/complicaciones , Indicadores de Salud , Lupus Eritematoso Sistémico/complicaciones , Fracturas Osteoporóticas/epidemiología , Síndrome de Sjögren/complicaciones , Absorciometría de Fotón , Adulto , Anciano , Algoritmos , Densidad Ósea , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Fracturas Osteoporóticas/etiología , Estudios Retrospectivos , Medición de Riesgo/métodos , Factores de Riesgo , Taiwán/epidemiología
4.
Lupus ; 28(5): 658-666, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30971165

RESUMEN

Lupus nephritis (LN) is the leading cause of mortality in lupus patients. This study aimed to investigate the treatment outcome and renal histological risk factors of LN in a tertiary referral center. Between 2006 and 2017, a retrospective observational study enrolled 148 biopsy-proven LN patients. After propensity score matching, 75 cases were included for further analysis. The classification and scoring of LN were assessed according to the International Society of Nephrology/Renal Pathology Society. Treatment response was evaluated by daily urine protein and urinalysis at two years after commencing induction treatment and the development of end-stage renal disease (ESRD). In total, 50.7% patients achieved complete remission (CR) or partial remission (PR), while 49.3% patients were categorized as nonresponders. Therapeutic responses in terms of CR/PR rates were associated with Systemic Lupus Erythematosus Disease Activity Index scores (odds ratio (OR): 1.34, 95% confidence interval (CI): 1.12-1.60, p = 0.001). Moreover, higher baseline creatinine levels (hazard ratio (HR): 2.10, 95% CI: 1.29-3.40, p = 0.003), higher renal activity index (HR: 1.30, 95% CI: 1.07-1.58, p = 0.008) and chronicity index (HR: 1.40, 95% CI: 1.06-1.85, p = 0.017) predicted ESRD. Among pathological scores, cellular crescents (HR: 4.42, 95% CI: 1.01-19.38, p = 0.049) and fibrous crescents (HR: 5.93, 95% CI: 1.41-24.92, p = 0.015) were independent risk factors for ESRD. In conclusion, higher lupus activity was a good prognostic marker for renal remission. Renal histology was predictive of ESRD. Large-scale prospective studies are required to verify the efficacy of mycophenolate in combination with azathioprine or cyclosporine in LN patients.


Asunto(s)
Inmunosupresores/uso terapéutico , Fallo Renal Crónico/etiología , Riñón/patología , Nefritis Lúpica/tratamiento farmacológico , Adolescente , Adulto , Azatioprina/uso terapéutico , Ciclosporina/uso terapéutico , Quimioterapia Combinada , Femenino , Humanos , Estimación de Kaplan-Meier , Fallo Renal Crónico/patología , Nefritis Lúpica/complicaciones , Masculino , Persona de Mediana Edad , Análisis Multivariante , Ácido Micofenólico/uso terapéutico , Puntaje de Propensión , Inducción de Remisión , Estudios Retrospectivos , Factores de Riesgo , Taiwán , Resultado del Tratamiento , Adulto Joven
5.
BMC Palliat Care ; 14: 58, 2015 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-26542798

RESUMEN

BACKGROUND: Malignant esophageal obstruction leads to dysphagia, deterioration in quality of life, and malnutrition. Traditional bedside nasogastric (NG) tube placement is very difficult under these circumstances. However, endoscopically assisted NG tube placement under fluoroscopic guidance could be an alternative option for establishing palliative enteral nutrition. This study aimed to compare the clinical outcomes of enteral tube feeding and esophageal stenting for patients with malignant esophageal obstruction and a short life expectancy. METHODS: Thirty-one patients were divided into 3 groups according to their treatment modality: NG tube (n = 12), esophageal stent group (n = 10), and supportive care with nil per os (NPO) (n = 9). Enteral nutrition, clinical outcomes, length of hospital stay, and median survival were evaluated. RESULTS: There were no significant baseline differences among the groups, except in age. The tube and stent groups had significantly higher enteral calorie intake (p = 0.01), higher serum albumin (p < 0.01), shorter hospital stay (p = 0.01), and longer median survival (p < 0.01) than the NPO group. The incidence of dislodgement in the tube group was significantly higher than in the stent group (58% vs. 20%, respectively; p = 0.01). However, stenting costs more than NG tube placement. CONCLUSIONS: Palliative enteral feeding by NG tube is safe, inexpensive, and has a low complication rate. Endoscopically assisted NG tube placement under fluoroscopic guidance could be a feasible palliative option for malignant esophageal obstruction for patients who have a short life expectancy.


Asunto(s)
Endoscopía/estadística & datos numéricos , Nutrición Enteral/métodos , Neoplasias Esofágicas/dietoterapia , Intubación Gastrointestinal/métodos , Cuidados Paliativos/métodos , Adulto , Anciano , Anciano de 80 o más Años , Endoscopía/normas , Neoplasias Esofágicas/complicaciones , Humanos , Persona de Mediana Edad , Cuidados Paliativos/normas , Estudios Retrospectivos
6.
Br J Oral Maxillofac Surg ; 53(2): 142-7, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25467247

RESUMEN

Oral erythroplakia is a precancerous lesion with high malignant potential, and resection is the recommended treatment. We designed a retrospective study to analyse the outcome of treatment in patients who had operations for oral erythroplakia. A total of 84 patients (74 men and 10 women, mean (SD) age 54 (12) years, range 29-83) were enrolled. Histopathologically the diagnoses were invasive carcinoma (n=3), dysplasia/carcinoma in situ (n=61), and squamous hyperplasia (n=20), and all patients were treated by carbon dioxide laser excision. There was no postoperative malignant transformation, but invasive carcinoma found after initial excision (n=3) was treated by further radical excision. The mean (SD) follow-up period was 46 (29) months (range 1-124), The postoperative recurrent rate was 14/84 (16.7%). The area of oral erythroplakia was the only factor associated with postoperative recurrence on univariate analysis, and was also the only independent factor that predicted postoperative recurrence in multivariate logistic regression analysis. An area exceeding 80 mm2 had the best predictive value (sensitivity=0.71, specificity=0.67) with a 5.1 times increased risk (odds ratio=5.1, CI 95% 1.45 to 18.05, p=0.01) of recurrence. Laser excision is effective for oral erythroplakia that is still confined to dysplasia of any degree, with low morbidity. The area of oral erythroplakia is a predictive factor for postoperative recurrence.


Asunto(s)
Eritroplasia/cirugía , Neoplasias de la Boca/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Consumo de Bebidas Alcohólicas , Areca , Carcinoma in Situ/cirugía , Eritroplasia/patología , Femenino , Estudios de Seguimiento , Humanos , Hiperplasia , Terapia por Láser/métodos , Láseres de Gas/uso terapéutico , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/patología , Invasividad Neoplásica , Recurrencia Local de Neoplasia/patología , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Factores de Riesgo , Sensibilidad y Especificidad , Fumar , Resultado del Tratamiento
7.
Genet Mol Res ; 13(1): 670-9, 2014 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-24615032

RESUMEN

Gilbert's syndrome is suspected in patients with unconjugated hyperbilirubinemia caused by decreased activity of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene in the absence of abnormal liver function and hemolysis. The major genetic variants underlying Gilbert's syndrome are TATA-box repeats of the promoter region and exon 1 G211A of the coding region, particularly in Asians. The efficacy of DNA melting curve analysis, however, has not been established for the G211A mutation. For rapid and accurate molecular diagnosis of Gilbert's syndrome, DNA melting curve analysis was evaluated for its genotyping capability not only for TATA-box repeats of the UGT1A1 promoter, but also for G211A of UGT1A1 exon 1. TA repeats within the TATA-box sequence and the exon 1 G211A mutation of the UGT1A1 gene were analyzed by DNA melting curve analysis. To evaluate the assay reliability, direct sequencing or polyacrylamide gel electrophoresis was used as a comparative method. All homozygous and heterozygous polymorphisms of A(TA)7TAA within the TATA-box allele and of exon 1 G211A mutants of the UGT1A1 gene were successfully identified with DNA melting curve analysis. DNA melting curve analysis is, therefore, an effective molecular method for the rapid diagnosis of Gilbert's syndrome, as it detects not only TATA-box polymorphisms but also the exon 1 G211A mutation located within the UGT1A1 gene.


Asunto(s)
Enfermedad de Gilbert/genética , Glucuronosiltransferasa/genética , Patología Molecular , Alelos , Pueblo Asiatico/genética , Exones , Genotipo , Enfermedad de Gilbert/diagnóstico , Humanos , Mutación , Desnaturalización de Ácido Nucleico/genética , Polimorfismo Genético , Regiones Promotoras Genéticas , TATA Box/genética
8.
Singapore Med J ; 55(6): e93-5, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24442188

RESUMEN

Hepatocellular carcinoma with colonic metastasis is rare. It mainly occurs by direct invasion and presents with bloody stools. We describe a patient with haematogenous metastasis to the rectum who presented with tenesmus. To our knowledge, such an association has not been reported previously. Colonic metastasis should be considered when patients with hepatocellular carcinoma present with bloody stools or tenesmus.


Asunto(s)
Carcinoma Hepatocelular/patología , Neoplasias Hepáticas/patología , Neoplasias del Recto/secundario , Carcinoma Hepatocelular/complicaciones , Resultado Fatal , Hepatitis B/complicaciones , Humanos , Neoplasias Hepáticas/complicaciones , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Neumonía por Aspiración/complicaciones
9.
Lupus ; 22(6): 554-61, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23478030

RESUMEN

Lupus nephritis (LN) is usually associated with widespread effacement of the podocytes' foot processes leading to proteinuria. Induction of urokinase receptor (uPAR) signaling in podocytes leads to foot process effacement and urinary protein loss via promoting podocytes' motility and kidney permeability in the glomerulus. Very little is known about uPAR signaling in LN. Mycophenolate mofetil (MMF), an immunosuppressive agent, efficiently modulates the development of LN in humans and mice, but there are no data concerning the direct uPAR involvement on podocytes in LN. The MMF efficiency and uPAR involvement signaling in NZB×NZW F1 lupus-prone mice were examined by proteinuria, renal function and pathology, immune complex deposits, and uPAR expression of podocytes by immunofluorescence staining and quantitative RT-PCR. After MMF treatment, the proteinuria (p < 0.01), BUN level (p < 0.05) and immunodeposition in glomeruli (p < 0.001) were significantly improved. Most important, the renal uPAR mRNA levels (p < 0.001) and uPAR protein level of podocytes (p < 0.001) were significantly reduced. The beneficial effect of MMF on LN could be attributed, at least in part, to the inhibition of uPAR expression in podocytes. These findings demonstrated uPAR could have potential as a predictive index for response to LN therapeutics.


Asunto(s)
Inmunosupresores/farmacología , Nefritis Lúpica/tratamiento farmacológico , Ácido Micofenólico/análogos & derivados , Receptores del Activador de Plasminógeno Tipo Uroquinasa/metabolismo , Animales , Nitrógeno de la Urea Sanguínea , Modelos Animales de Enfermedad , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Nefritis Lúpica/fisiopatología , Ratones , Ratones Endogámicos NZB , Ácido Micofenólico/farmacología , Podocitos/efectos de los fármacos , Podocitos/metabolismo , Proteinuria/tratamiento farmacológico , Proteinuria/etiología , Receptores del Activador de Plasminógeno Tipo Uroquinasa/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal
11.
Lupus ; 21(13): 1385-96, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22892208

RESUMEN

T helper type 17 (Th17) cells, a novel distinct subset of Th cell, can secrete interleukin (IL)-17 in humans. Although recent data suggest that Th17 cells and IL-17 play an important role in the pathogenesis of lupus nephritis (LN), the expression of Th17-related cytokines in the kidneys of SLE patients has not been studied in detail. In the present study, we investigated circulating Th17-cell frequencies using flow cytometry and serum Th17-related cytokine levels by enzyme-linked immunosorbent assay (ELISA) in 24 LN patients (17 patients with class IV and seven patients with class V) and 12 healthy controls. We also investigated glomerular Th17-related cytokine expression in LN patients and minimal change nephropathy (MCN) patients using immunohistochemistry. Our results showed significantly higher median frequencies of circulating Th17 cells in LN patients (0.68%) than in healthy controls (0.12%, p < 0.001). Serum levels of IL-17, IL-6 and IL-23 were significantly higher in LN patients (median 7.26, 232.60 and 37.01 pg/ml, respectively) than in healthy controls (median 0.82, 34.60 and 7.42 pg/ml, respectively; all p < 0.001). Circulating Th17-cell frequencies were positively correlated with SLEDAI, renal SLEDAI and histological activity index, the degree of cellular crescent and endocapillary proliferation. Significantly higher levels of glomerular IL-17 and IL-23 expression were observed in renal biopsies from class IV LN patients as compared to those from MCN patients and normal controls. Glomerular IL-17 and IL-23 expression levels were positively correlated with renal SLEDAI and histological activity index for LN patients. Our results suggest the potential role of the IL-23/Th17 axis in the intra-renal inflammation of SLE.


Asunto(s)
Citocinas/sangre , Glomérulos Renales/inmunología , Nefritis Lúpica/inmunología , Células Th17/inmunología , Adulto , Biopsia , Estudios de Casos y Controles , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Humanos , Inmunohistoquímica , Interleucina-17/sangre , Interleucina-18/análisis , Interleucina-23/sangre , Interleucina-6/sangre , Glomérulos Renales/patología , Nefritis Lúpica/sangre , Nefritis Lúpica/patología , Masculino , Persona de Mediana Edad , Nefrosis Lipoidea/inmunología , Pronóstico
15.
Int J Clin Pract ; 61(7): 1126-30, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17343672

RESUMEN

The aim was to study the effects of listening to music on gastric myoelectrical activity in healthy humans. Gastric myoelectrical activity was recorded using surface electrogastrography from 17 healthy volunteers before and for 30 min after they listened to music. All subjects listened to the same music. Ten perceived the music as enjoyable and seven did not. The percentages of normal slow wave, dominant frequency and dominant power did not differ significantly between baseline and during music intervention. An analysis of covariance model that included the subjects' feelings about the music and dominant power showed significantly higher dominant power during music intervention in subjects who enjoyed the music (p < 0.01). In the individuals who enjoyed the music, dominant power (55.0 +/- 9.2 dB) was significantly higher during music intervention than at baseline (49.5 +/- 6.8 dB, p = 0.03). In the subjects who did not enjoy the music, dominant power was significantly lower during music intervention than at baseline (48.8 +/- 6.8 and 55.7 +/- 6.2 dB, respectively; p < 0.01). Listening to enjoyable music increases the amplitude of gastric myoelectrical activity in healthy humans. Music therapy may improve gastric motility and may be used to stimulate gastric emptying.


Asunto(s)
Vaciamiento Gástrico/fisiología , Musicoterapia , Complejo Mioeléctrico Migratorio/fisiología , Adulto , Análisis de Varianza , Electromiografía/métodos , Femenino , Humanos , Masculino
17.
Lupus ; 14(4): 321-5, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15864919

RESUMEN

Spontaneous tendon rupture in a patient with systemic lupus erythematosus (SLE) is a rare but potentially disabling complication. Minor trauma, local inflammation and long term corticosteroid therapy are regarded as possible causes. However, ischemic necrosis of the tendon resulting from hypercoagulability and methyl prednisolone (MTP) pulse therapy has not been reported. We present a 20-year old female, newly diagnosed with lupus, who has high titer antiphospholipid antibodies, hyperhomocysteinemia and protein S deficiency. Her severe clinical symptoms of lupus were improved after MTP pulse therapy. Several days later, cold sensation over the right lower leg developed. On day 15 after pulse therapy, acute onset of right heel pain occurred when she was ascending stairs. Rupture of the right Achilles tendon was demonstrated by sonography and MRI. A Doppler sonography revealed narrowing and abrupt cessation of blood flow in the right popliteal artery. Heparin treatment was started. The angiography performed two days after heparinization revealed narrow caliber and decreased flow of the right tibial artery below the right ankle. Surgical repair of the tendon was successful and the pathology of the resected tendon revealed focal necrosis, degeneration and capillary proliferation. MTP pulse therapy in a lupus patient with hypercoaguable state with hyperhomocysteinemia, protein S deficiency and high titer antiphospholipid antibodies may cause spontaneous tendon rupture.


Asunto(s)
Tendón Calcáneo/efectos de los fármacos , Tendón Calcáneo/patología , Antiinflamatorios/efectos adversos , Lupus Eritematoso Sistémico/tratamiento farmacológico , Metilprednisolona/efectos adversos , Tendón Calcáneo/irrigación sanguínea , Adulto , Antiinflamatorios/administración & dosificación , Anticuerpos Anticardiolipina/sangre , Femenino , Humanos , Hiperhomocisteinemia/complicaciones , Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/patología , Metilprednisolona/administración & dosificación , Necrosis , Arteria Poplítea/patología , Deficiencia de Proteína S/complicaciones , Rotura Espontánea
18.
J Viral Hepat ; 12(3): 283-91, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15850469

RESUMEN

Previous studies in Caucasian patients showed treatment of chronic hepatitis C with pegylated interferon/ribavirin was well tolerated, and produced a higher response rate especially in genotype 1 infections. However, it is unknown whether this conclusion can be extrapolated to patients with Chinese ethnic origin. A total of 153 patients with biopsy-proven chronic hepatitis C were randomly assigned to receive either weekly injection of peginterferon alpha-2b 1.5 mcg/kg plus oral ribavirin (1000 or 1200 mg/day, depending on body weight) (PEG group, n = 76) or 3 MU of interferon alpha-2b t.i.w. plus ribavirin (IFN group, n = 77) for 24 weeks. Sustained virological response (SVR) was defined as the sustained disappearance of serum hepatitis C virus (HCV) RNA at 24 weeks after the end of treatment by polymerase chain reaction assay. Baseline demographic, viral and histological characteristics were comparable between the two groups. Using an intent-to-treat analysis, HCV genotype 1 patients showed a significantly higher SVR in patients receiving PEG-IFN rather than IFN (65.8%vs 41.0%, P = 0.019), but no difference was found in genotype non-1 patients (PEG vs IFN: 68.4%vs 86.8%, P = 0.060). Genotype 1 patients (28.6%) in the PEG-IFN group relapsed, as compared with 52.9% in the IFN group (P = 0.040). Multivariate analyses showed early virological response at week 12 of therapy and genotype non-1 were significant predictors to SVR. As compared with the IFN group, patients receiving PEG-IFN had a significantly higher rate of discontinuation, dose reduction, fever, headache, insomnia, leucopenia and thrombocytopenia. In genotype 1 chronic hepatitis C Chinese patient, PEG-IFNalpha2b ribavirin had significantly better SVR and lower relapse rate when compared to IFN/ribavirin. Both regimens can be recommended for genotype non-1 chronic hepatitis C Chinese patients. However, a higher rate of adverse events and discontinuance of therapy were noted in patients treated with PEG-IFNalpha2b ribavirin.


Asunto(s)
Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/tratamiento farmacológico , Interferón-alfa/administración & dosificación , Ribavirina/administración & dosificación , Adolescente , Adulto , Anciano , Biopsia con Aguja , Distribución de Chi-Cuadrado , Intervalos de Confianza , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Interferón alfa-2 , Interferón-alfa/efectos adversos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Polietilenglicoles , Probabilidad , Proteínas Recombinantes , Ribavirina/efectos adversos , Medición de Riesgo , Índice de Severidad de la Enfermedad , Método Simple Ciego , Taiwán , Factores de Tiempo , Resultado del Tratamiento
19.
Ann Rheum Dis ; 63(10): 1300-6, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15361391

RESUMEN

OBJECTIVE: To determine the type 1 T helper (Th1)/type 2 T helper (Th2) balance in the peripheral blood (PB) and pathological tissues of patients with active untreated adult onset Still's disease (AOSD). METHODS: The percentages of interferon gamma (IFNgamma)- and interleukin (IL)4-producing Th cells in the PB of 20 patients with active untreated AOSD, 20 patients with active rheumatoid arthritis (RA), and 20 healthy controls were determined by intracellular staining and flow cytometry. Serum levels of IL18 and soluble IL2 receptor were measured by enzyme linked immunosorbent assay. Levels of IFNgamma and IL4 messenger (m) RNA expression were examined by real time quantitative polymerase chain reaction in biopsy specimens of evanescent rash and synovitis from 8 patients with AOSD. RESULTS: Significantly higher IFNgamma-producing Th cells and Th1/Th2 ratio in PB were found in patients with AOSD than in healthy controls. Percentages of IFNgamma-producing Th cells and Th1/Th2 ratio in PB correlated significantly with clinical activity score and serum IL18 levels in patients with AOSD. Increased ratio of Th1/Th2 cytokine transcripts was seen in the biopsy specimens of evanescent rash and synovitis from patients with AOSD compared with normal skin controls and patients with OA. Th cell cytokine pattern in PB and cytokine mRNA expression in synovium were similar for patients with AOSD and with RA. After 3 months' treatment, clinical remission was associated with a marked decrease in the percentages of cytokine-producing Th1 cells, but not of the Th2 cells. CONCLUSION: A predominance of Th1 cytokine may precipitate the pathogenesis of AOSD.


Asunto(s)
Citocinas/sangre , Enfermedad de Still del Adulto/inmunología , Células TH1/inmunología , Adulto , Anciano , Artritis Reumatoide/inmunología , Femenino , Expresión Génica , Humanos , Interferón gamma/biosíntesis , Interferón gamma/genética , Interleucina-18/sangre , Interleucina-4/biosíntesis , Interleucina-4/genética , Masculino , Persona de Mediana Edad , ARN Mensajero/genética , Receptores de Interleucina-2/sangre , Enfermedad de Still del Adulto/tratamiento farmacológico , Membrana Sinovial/inmunología , Células Th2/inmunología
20.
Clin Rheumatol ; 21(4): 271-4, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12189451

RESUMEN

Progressive systemic sclerosis (PSS) may involve any portion of the gastrointestinal tract, including the colon. Constipation is common in patients with PSS. Cisapride, a benzamide derivative, is a potentially useful agent in the treatment of chronic idiopathic constipation. The effect of cisapride on colonic transit was evaluated in 16 PSS patients by a radionuclide colonic transit method. Each patient received cisapride orally three times a day for a week. The results showed acceleration in colonic transit in response to cisapride. We conclude that cisapride is effective in the treatment of constipation in patients with PSS.


Asunto(s)
Cisaprida/uso terapéutico , Estreñimiento/tratamiento farmacológico , Fármacos Gastrointestinales/uso terapéutico , Tránsito Gastrointestinal/efectos de los fármacos , Esclerodermia Sistémica/tratamiento farmacológico , Adulto , Anciano , Colon/diagnóstico por imagen , Colon/efectos de los fármacos , Colon/fisiopatología , Estreñimiento/diagnóstico por imagen , Estreñimiento/etiología , Femenino , Tránsito Gastrointestinal/fisiología , Humanos , Masculino , Persona de Mediana Edad , Cintigrafía , Esclerodermia Sistémica/complicaciones , Pentetato de Tecnecio Tc 99m , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...